Paid Clinical Trials Grand Forks
Discover 24 paid clinical trials in Grand Forks, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Dichoptic TreatmentDichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Sponsor:
Jaeb Center for Health Research
Location:
Code:
NCT06380517
Conditions
Amblyopia
Eligibility Criteria
Sex: All
Age: 4 - 7
Healthy Volunteers: Not accepted
Interventions
Luminopia
Eye Patch
Lasofoxifene & FulvestrantEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Sponsor:
Sermonix Pharmaceuticals Inc.
Location:
Code:
NCT05696626
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lasofoxifene in combination with abemaciclib
Fulvestrant in combination with abemaciclib
Methylated DNA MarkersLeveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Sponsor:
Mayo Clinic
Location:
Code:
NCT05051722
Conditions
Endometrial Cancer
Cervical Cancer
Atypical Endometrial Hyperplasia
Cervical Dysplasia
Adnexal Mass
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tampon Collection
Blood Collection
At-Home TherapyAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer
Sponsor:
Mayo Clinic
Location:
Code:
NCT05969860
Conditions
Advanced Anal Carcinoma
Advanced Biliary Tract Carcinoma
Advanced Bladder Carcinoma
Advanced Breast Carcinoma
Advanced Carcinoid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Clinical Encounter
Home Health Encounter
Quality-of-Life Assessment
Questionnaire Administration
V940 vs. PembrolizumabA Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06077760
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
V940
Pembrolizumab
Placebo
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dichoptic TreatmentDichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Sponsor:
Jaeb Center for Health Research
Location:
Code:
NCT06524882
Conditions
Amblyopia
Eligibility Criteria
Sex: All
Age: 8 - 12
Healthy Volunteers: Not accepted
Interventions
Vivid Vision
Luminopia
Optical Correction
Regional RadiotherapyRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT03488693
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Radiation
No Radiation
Enlicitide DecanoateEnlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06008756
Conditions
Arteriosclerosis
Hypercholesterolaemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enlicitide Decanoate
Placebo
Darolutamide & Hormone TherapyTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Sponsor:
NRG Oncology
Location:
Code:
NCT05050084
Conditions
Prostate Adenocarcinoma
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bicalutamide
Buserelin
Darolutamide
Degarelix
Flutamide
Shorter Duration RadiationTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT05946213
Conditions
Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Computed Tomography
External Beam Radiation Therapy
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration